Background and Purpose-Exposure to vascular risk factors has a gradual deleterious effect on brain MRI and cognitive measures. We explored whether a pattern of these measures exists that predicts stroke and Alzheimer disease (AD) risk. 
S
troke and dementia are the most common neurological diseases in the elderly.
1,2 They frequently coexist, 3, 4 and certain vascular risk factors are associated with both. 5 A prodromal phase exists in Alzheimer disease (AD) which is well characterized. People with mild cognitive impairment have a greater risk of developing AD in the future, 6 and changes in cognitive performance as early as 22 years before any clinical manifestations of AD have been demonstrated. 7 Clinical AD may also be preceded by alteration in structural brain volumes, mainly in the hippocampus, 8, 9 but also in other brain regions, such as temporal, 10, 11 parietal, 10, 11 posterior, 12 and frontal. 12 Unlike AD, stroke often occurs without prior warning. Multiple risk factors for stroke have been recognized, 13 and an individual's risk of future stroke can be estimated on the basis of information on one's vascular risk factors. 14 In addition, stroke risk factors have been related to brain MRI changes 15, 16 and to poor cognitive function. 5, 17 Nevertheless, it is not clear whether such structural and cognitive changes precede the occurrence of clinical stroke and, therefore, can serve as intermediate markers between one's vascular burden and the risk of clinical stroke.
We hypothesized that the effect of vascular risk factors on MRI and cognitive measures would be detectable as a specific structural and cognitive pattern which, in turn, predicts incident stroke. We used AD as an outcome to examine whether these patterns are specific for stroke rather than reflective of generalized brain aging.
Methods
The Framingham Heart Study (FHS) is a longitudinal communitybased cohort study which was initiated in 1948 with the enrollment of 5209 participants aged 28 to 62 years (original cohort). In 1971, the offspring and spouses of the offspring were enrolled as the offspring cohort. Since the study's inception, participants have had serial examinations, including standardized interviews, physician examinations, and laboratory testing. More details have been provided elsewhere.
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exclusion of participants with prevalent stroke or dementia, and those with neurological conditions that could affect their cognition, with incomplete follow-up or education information and people aged <55 years, 1679 people aged >55 years were available for cognitive analysis, and among them, 1469 also had brain MRI measures. A cognitive test battery was administered to the original cohort participants between 1976 and 1978; most of these tests were included in the subsequently designed offspring battery. 21 Of the participants who were tested (n=2123), 1456 were native English speakers, had complete follow-up information, and did not have prevalent stroke or dementia, meeting an inclusion criteria for the cognitive analyses. Approximately 23 years later, surviving participants from the original cohort were invited to undergo brain MRI. Among the 478 alive in 2005, 266 participants had MRI information, and after excluding individuals with prevalent stroke or dementia or with neurological conditions that might confound the assessment of cognitive function and structural brain measurement, 224 people were available for these MRI analyses.
Prospective surveillance for incident stroke and AD is ongoing and for these analyses data were used for the period extending 10 years from the date of the MRI and cognitive testing or until December 2009, whichever occurred earlier.
Data were obtained under a protocol approved by the Institutional Review Board of the Boston University Medical Center and informed consent was obtained from all participants.
Methodology for Volumetric Brain MRI
Participants were evaluated with a 1 or 1.5-Tesla Siemens Magnetom scanner. Three-dimensional (3D) T1 and double echo proton density and T2 coronal images acquired in 4-mm contiguous slices were performed. All images were transferred to the centralized reading center at the University of California-Davis Medical Center and analyses were performed on QUANTA 6.2, a custom-designed image analysis package. All images were read centrally, blind to the subject's identity, age, sex, exposure to stroke risk factors, and cognitive performance on cognitive testing. Total cerebral brain volume (TCBV), hippocampal volume (HPV), and white matter hyperintensity volume (WMHV) assessments, as well as their inter-rater reliability, have been described previously. [22] [23] [24] [25] [26] Brain volume calculation was performed using semiautomated analysis of pixel distributions on the basis of mathematical modeling of MRI pixel intensity histograms for cerebrospinal fluid and brain matter (white matter and gray matter) to determine the optimal threshold of pixel intensity to best distinguish cerebrospinal fluid from brain matter. 25 TCBV was computed as the ratio of total brain parenchymal volume to total cranial volume to correct for differences in head size.
WMHV was expressed as a proportion of total cranial volume to correct for head size and was log transformed for all regression analyses. HPV was measured as the sum of right and left hippocampal volumes assessed using in-house software that allowed for 3D visualization at ×3 magnification of the image. Areas included were the CA1-CA4 fields, dentate gyrus, and the subicular complex. On a coronal 3D MRI data set resliced to be aligned perpendicular to the long axis of the hippocampus, borders were traced on contiguous 1.5-mm coronal slices, and these slice-specific volumes were summed to give hippocampal volume for each side.
Finally, the presence or the absence of silent cerebral infarcts (SCIs) was determined manually by the operator, on the basis of size (≥3 mm), location, and imaging characteristics of the lesion.
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Cognitive Tests
Subjects were administered a cognitive test battery using standard administration protocols and trained examiners. Description of the tests administered and the cohorts in which they were administered to are presented in Table 1 
Outcomes
All participants of the FHS are under continuous surveillance for stroke and impairment in cognitive function. We have previously outlined our screening and surveillance methods for the development of stroke 14 or dementia. 28 In brief, stroke was defined as an acuteonset focal neurological deficit of presumed vascular pathogenesis lasting ≥24 hours. All stroke subtypes were included in the analyses. Ischemic stroke was diagnosed if a focal neurological deficit was documented, imaging showed an infarct that correlated with the clinical deficit, or an infarct was documented at autopsy. Hemorrhagic stroke was defined on the basis of brain imaging, lumbar puncture, or autopsy.
AD was diagnosed on the basis of criteria of the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) for definite, probable, or possible AD. 29 
Statistical Analysis
We used multivariable Cox regression to examine the associations of MRI and cognitive measures with incident stroke and AD among the offspring cohort. Independent variables were defined as continuous or dichotomous. To allow comparisons between performance in different cognitive tests and between different regional brain volumes, we used continuous variables transformed using standardized residuals (Z scores) from cohort-specific regressions onto age (and education for the cognitive outcomes). Cognitive measures were dichotomized with a cutoff set at Z=−1.5 and cognitive deficit in a specific domain was defined as a Z score below that cutoff. The cutoff of 1.5 SD below the mean is in accordance with previous studies. [30] [31] [32] [33] Brain MRI measures were divided into cohort-specific quintiles, and the most abnormal quintile (for TCBV and HPV this is the bottom quintile and for WMHV the top quintile) was compared with the rest. The models were adjusted for age and sex and in a subsequent model additionally for hypertension, smoking, prevalent diabetes mellitus, body mass index, and ApoEε4 genotype status. In secondary analyses, we examined these associations in the original cohort. ApoEε4 genotype information was not available as a covariate in all people in the original cohort. In addition, we ran sensitivity analyses using only the outcomes of probable AD.
We ran Cox-proportional hazards models relating the number of identified predictor variables for stroke to risk of subsequent stroke and AD and illustrate these using comulative hazard function.
Finally, we estimated net reclassification improvement, using continuous Cox-proportional hazards-based models, 34 observed on adding each of the statistically significant predictors of stroke risk in a stepwise regression model to the Framingham stroke risk profile (FSRP). The FSRP provides an estimate of the 10-year risk of stroke for a given individual based on age, sex, and measurements of systolic blood pressure, antihypertensive therapy, diabetes mellitus, smoking status, history of cardiovascular disease, and the presence of atrial fibrillation or the left ventricular hypertrophy on the ECG. It has been previously described and validated for stroke prediction risk both at Framingham and in other populations. [35] [36] [37] Analyses were performed using Statistical Analyses System software version 9.2 (SAS Institute, Cary, NC).
Results
The baseline characteristics of study participants from the offspring cohort and the original cohort (both at the time of the cognitive assessment and at the MRI examination) are presented in Table 2 . The mean age of the offspring was 65.7±7.0 years. The mean ages of the original cohort at the cognitive assessment and at the later MRI examination were 67.5±7.3 and 84.8±3.3 years, respectively. The mean duration of follow-up for stroke was 7.4±1.7 years for the offspring cohort, 8.7±2.5 years for the original cohort, and 5.9±2.3 for the original cohort survivors who underwent MRI ( Figure 1 ).
Predictors of Stroke
Cognitive Measures
Among the offspring, 55 of 1679 developed a stroke. Poorer performance on TrB, a measure of executive function, was associated with a higher risk of stroke (hazard ratio [HR], 1.27; 95% confidence interval [CI], 1.01-1.59), and this association did not attenuate after additional adjustments ( Table 3 ). The risk of future stroke more than doubled in individuals whose executive function performance fell below a predefined threshold (using TrB; cognitive Z scores less than −1.5) compared with those with intact executive function (HR, 2.27; 95% CI, 1.06-4.85), even after adjustment for concomitant levels of vascular risk factors (HR, 2.25; 95% CI, 1.05-4.86; Table 4 ). Seventeen percent of people with poor performance on TrB and 12% of people with better performance had SCI (P=0.200). Adjustment for SCI also did not Of the 1445 participants from the original cohort, 72 were classified as having at least mild AD during the follow-up (7 were possible AD, 3 of whom had a clinical stroke, and the rest were probable AD). The findings here were comparable with those in the offspring cohort. Of the tests which were administered only in this sample, a measure of executive function (Controlled Word Association Fluency Test) was associated with AD (HR, 1.47; 95% CI, 1.12-1.92); however, the association was not significant after additional adjustments or when a threshold model was applied. In addition, another test that measures executive function, Digit Span Backward, was not associated with AD (Tables I and II in the online-only Data Supplement).
MRI Measures
During the follow-up period, 28 of 1469 offspring participants who underwent MRI developed AD (all were probable AD). Lower HPV predicted increased risk of AD (Tables 2 and 4) , with >4× the risk of AD for those at the bottom HPV quintile (Table 4 ). The association with continuous HPV attenuated after additional adjustment for vascular risk factors and ApoEε4 genotype (Table 3) , but remained significant in the threshold model (Table 4) .
Thirty-seven participants of the original cohort of 224 people who underwent brain MRI (22% of the original cohort participants who survived until 1999 when the MRI evaluations began) were diagnosed with AD (2 were possible AD, none of whom had a clinical stroke and the rest were probable AD). In this sample of elderly people, HPV predicted future AD as in the offspring; however, in addition, low TCBV was a strong predictor of AD (HR, 6.69; 95% CI, 2.62-17.09; Tables I and II in the online-only Data Supplement). The results were similar when we used probable AD as an outcome rather than possible AD in the original cohort.
Overall Patterns
The age-adjusted bivariate intercorrelations were 0.063, 0.047, and 0.019 for the following pairs of stroke-associated Values are n (%) or mean±SD. *Hypertension was defined as either systolic blood pressure ≥140 mm Hg or diastolic blood pressure ≥90 mm Hg or the use of antihypertensive medication.
†Diabetes mellitus as a recorded random blood glucose level ≥200 mg/dL (11.1 mmol/L), a previous diagnosis of diabetes mellitus, or the use of insulin or a hypoglycemic agent.
by guest on September 28, 2016 http://stroke.ahajournals.org/ Downloaded from indicator variables, respectively: TCBV and TrB, WMHV and TrB, and TCBV and WMHV. There was a dose-dependent relationship between the number of these 3 stroke predictors and the risk of developing stroke (P<0.001), but not AD (Figure 2) .
The net reclassification improvement on adding WMHV to the FSRP was estimated at 0.37 and was statistically significant (95% CI, 0.02, 0.85). The net reclassification improvement on adding TCBV or TrB to the FSRP was not statistically significant.
Discussion
Our findings demonstrate a specific pattern of cognitive deficits and brain MRI measures that precede the occurrence of stroke. Hence, we suggest that vascular risk factors may have a continuous subclinical deleterious effect on the brain, which in turn may manifest as a clinical stroke. Individuals with a deficit in executive function, with low total brain volume or large white matter hyperintensity volumes, had twice or more the risk of future stroke, and having more of these markers was associated with a gradual increase in stroke risk. This pattern was specific to stroke and was not demonstrated in AD.
Previous literature has suggested that people with cognitive impairment may have a higher risk of subsequent stroke, independently of vascular risk factors, and emphasized the role of cerebrovascular disease in cognitive impairment. 38, 39 Our finding that in both the offspring and the original cohorts measures of executive function were associated with incident stroke is reasonable considering that these measures reflect the integrity of the frontal lobe which is more prone to subclinical vascular injury. 40, 41 However only TrB, a measure of executive function, predicted stroke independently of vascular risk factors. This is in accordance with another study that demonstrated an independent association of TrB (and not Trail Making Test A or the Mini Mental State Examination) to subsequent risk of brain infarction in a sample of 930 elderly men followed for 13 years. 39 The presence of SCI could not explain, in our analysis, the association between TrB and risk of incident stroke.
Although TrB also predicted AD, total brain volume and white matter hyperintensity volume were specific for stroke prediction. We and others have previously shown that white matter hyperintensity volume is related to risk of incident stroke 42, 43 ; however to our knowledge, we are demonstrating for the first time an association between total brain volume and risk of incident stroke. Unlike white matter hyperintensity volume, which was an independent predictor, the association of total brain volume with risk of stroke attenuated after controlling for vascular risk factors, and in the threshold model was no longer significant. Moreover, white matter hyperintensity volume significantly improved the predictive value compared with the ‡Variables are log-transformed. FSRP, a finding that is supported by a recent study, 44 whereas total brain volume did not. Therefore, we conclude that total brain volume reflects current vascular burden, whereas white matter hyperintensity volume may represent cumulative vascular risk or, albeit less likely, a distinct, nonvascular mechanism. Keeping this in mind, the fact that total brain volume was related to risk of stroke in the younger offspring sample and to risk of AD in the elderly survivors from the original cohort is plausible because vascular burden is associated with both conditions but AD occurs later in life and the changes preceding it might be delayed until the eighth and subsequent decades. 45, 46 Similarly, the absence of associations between any brain MRI measure and risk of incident stroke among the survivors of the original cohort may be explained by a healthy survivor bias. Prior studies have also demonstrated a negative association between total brain volume and vascular burden as assessed by the FSRP. 24 Moreover, presence and progression of lacunar infarcts, 47 as well as white matter hyperintensity volume, 48, 49 were shown to be associated with a greater decrease in total brain volume. In the present analysis, the associations of both total cerebral brain volume and white matter hyperintensity volume with incident stroke could be only partially explained by the concomitant presence of SCIs. Previous studies have demonstrated the existence of a long preclinical phase for AD, which involves impairment in multiple cognitive domains, 7, 50 as well as changes in brain MRI measures. [8] [9] [10] [11] [12] Accordingly, in the current study, multiple tests, such as verbal and visual memory, abstract reasoning and language, were predictive of AD risk. Interestingly, measures of executive function (TrB) in the offspring but not in the original cohort (DFB, Controlled Word Association Fluency Test) strongly predicted the risk of incident AD. This finding is especially intriguing considering the fact that all cases of AD in the offspring were classified as probable AD and thus the association between TrB and AD was less likely to be driven by cases of mixed AD and vascular pathology. Inconsistency about the ability of measures of executive function to predict AD exists also in the literature 7, [51] [52] [53] and may be because of differences in tests (Digit span test is less demanding than Trail making), in sample characteristics, or because of different time courses between the baseline assessment and onset of clinical dementia. 53 Our study demonstrates a strong association between hippocampal volume and future AD risk which is in line with prior studies 8, 9 ; however, our observation that low hippocampal volume is related to AD risk more strongly among those at late middle-age as compared with the elderly (bottom quintile of hippocampal volume confers 4× the risk in the offspring compared with a doubling of the risk in the original cohort) is intriguing and needs further exploration.
The strengths of this study are its large sample and its prospective, population-based design, with a comprehensive cognitive battery and volumetric MRI measures at baseline, and a careful surveillance for clinical outcomes. The fact that the same methods and surveillance were applied to multiple generations enabled us to compare the 2 samples which were, for the MRI measures, also of different ages. Also, compared with previous publications, this study included a younger sample with a mean age of only 66 years. Limitations include the potential for healthy survivor bias among participants from the original cohort who underwent MRI and the predominantly European origin and highly educated status of our samples that limits the study generalizability.
Stroke often occurs without prior warning, and when clinical symptoms appear, it is often too late for an effective treatment. Thus, it is of great importance to define biomarkers for early detection of people who are at a higher risk. These biomarkers can then help identify candidates who would benefit maximally from preventive interventions, help define end points for clinical trials and endophenotypes for genetic studies, and contribute to the creation of a composite risk score for stroke. Future studies are warranted to validate these markers, to study the time points in one's lifespan at which they would be most useful and to integrate these with other demographic, circulating and imaging biomarkers, both established and novel, to improve risk prediction.
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